Top Markets
Coin of the day
InnoCan Pharma Corporation InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO
株式のランク #33466
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
株価
$1.69
最終同期: 2026-08-13
時価総額
$7.59M
変化(1日)
2.22%
変化(1年)
-84.04%
CA
取引 InnoCan Pharma Corporation (INNO)

カテゴリー

Bの時価総額のINNOの価格
InnoCan Pharma Corporation InnoCan Pharma Corporation
INNO
$1.69
の時価総額 InnoCan Pharma Corporation(INNO)
時価総額: $7.59M
August 2026時点で、InnoCan Pharma Corporation の時価総額は $7.59M です。これは、当社のデータによると、InnoCan Pharma Corporation が世界で33466th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
InnoCan Pharma Corporation の時価総額の履歴(2019 から 2026 まで)
INNO最も人気のあるトップ5と比較stocks
INNOの価格 資産b bの市場 結果
InnoCan Pharma Corporation InnoCan Pharma Corporation
$1,211,812 $7.59M
$5.452T +71,787,367.58%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$998,018 $7.59M
$4.490T +59,122,239.92%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$925,197 $7.59M
$4.162T +54,808,393.81%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$817,158 $7.59M
$3.676T +48,408,138.53%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$629,713 $7.59M
$2.833T +37,303,988.36%